Ongoing Clinical Trials

Indication
Institution
Department
Principal Investigator
Protocol Title
TMU-JIRB No. Protocol Title Indication Institution Department Principal Investigator Contact
N202306117 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-0616 in Adults With Hypercholesterolemia Hypercholesterolemia TMUH Cardiology Chun-Yao Huang Yin-Ju Chen
0227372181 #7606
N202008042 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of U101 Oral Capsules in the Prevention of Uncomplicated Recurrent Urinary Tract Infections (rUTIs) in Women Urinary Tract Infections TMUH Urology MING-CHE LIU Yin-Ju Chen
02-27372181 #7606
N202207029 Clinical Validation of Taking Bao-sang-li-qing in Adults with Non-Alcoholic Fatty Liver Non-Alcoholic Fatty Liver TMUH Urology MING-CHE LIU Yin-Ju Chen
02-27372181 #7607
N202308011 A Phase 3/3b, Randomized, Observer-blind, Multicenter Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Subunit Inactivated Influenza Vaccine Compared to a Quadrivalent Influenza Vaccine in Adults ≥65 Years of Age Influenza Vaccine TMUH Urology MING-CHE LIU Feng-Yi Chou
0227372181 #7602
N202211058 Clinical evaluation on accuracy of HL158 series Blood Pressure Monitor High Blood Pressure/Hypertension TMUH Urology MING-CHE LIU Pi-Wen Hsu
0987610280
N201701024 Human Blank Matrix Collection in Healthy Volunteers under Fasting Conditions Used in Method Development, Validation and Sample Analysis Healthy Volunteer TMUH Urology MING-CHE LIU Feng-Yi Chou
02-27372181 #7602
N202005098 Cell function test and cell process validation of autoimmune cell products Cell Therapy TMUH Urology MING-CHE LIU Feng-Yi Chou
02-27372181 #7603
N202206054 The clinical verification plan of GB COVID-19 Ag Saliva for home-using COVID-21 TMUH Urology MING-CHE LIU Hsiang-Yun Huang
0987841201
N202303052 ON-TRK: PrOspective Non-interventional study in patients with locally advanced or metastatic TRK fusion cancer treated with larotrectinib Lung Cancer TMUH Pediatrics Yen-Lin Liu Wei-Ling Lan
0970405675
N202011055 SERENA-4: A Randomised, Multicentre, Double-Blind, Phase III Study of AZD9833 (an Oral SERD) plus Palbociclib versus Anastrozole plus Palbociclib for the Treatment of Patients with Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease Breast Cancer TMUH Hematology and Oncology Jia-Ruey Tsai Yi-Ann Chen
02-27372181 #7633
1 2 3 4 5 6 7 8 9 10 11 12 13 / 13

TOP